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'An older person suffering a fall from standing height is now the commonest type of major trauma in the national database'. 1 This observation in the 2017 UK TARN report on major trauma reflects a stark change in the epidemiology of fragility fractures and has profound consequences for healthcare systems around the world. Rapid action is required if we are to meet what is likely to be a sustained and unrelenting increase in the volume and complexity of trauma cases in older patients.
The burden of disease is massive. In the year 2000, there were an estimated nine million new fragility fractures worldwide and 50 million people living with the consequences of these injuries. 2 We know that sustaining a hip fracture has a profound and long-lasting effect on quality of life persisting beyond one year post injury. 3 The associated costs are staggering -in Europe alone, the estimated costs of fragility fracture care were E37 billion in 2010. 4 This burden of disease and associated health and social care cost is set to increase exponentially. We are witnessing an unprecedented demographic shift; a shift towards an older, frailer but still active adult population. The so-called 'longevity miracle'. We are beginning to observe this effect on the epidemiology of fragility fractures and major trauma in Europe, but the impact in Asia Pacific and South America has yet to be realised. The term 'silver trauma', while not welcomed by all, acknowledges this demographic shift and brings with it the current reality that trauma in the elderly has worse outcomes and increased mortality compared with similar injuries in younger people. 1 A recent prospective cohort study also reflects the increasing incidence of complex fracture patterns, open fragility fractures and older adults with multiple fractures. 5 This increasing burden and complexity of injuries mean that societies and healthcare systems are heading towards a potential crisis with unprecedented demands on resources. Our ability to meet these challenges will depend on improvements in a number of areas not least: multi-disciplinary acute care, rehabilitation and secondary fracture prevention. These will involve changes in the way in which we coordinate and deliver care both in and out of hospital. 6 We will need highquality data, including national registries. Research in these areas has also been highlighted as a priority by the patients themselves in a recent national research priority setting exercise. 7 The UK NICE osteoporosis guideline 8 states that 'fracture risk is currently assessed opportunistically' and more efficient ways are required to identify at-risk patients for assessment and possible treatment. This is particularly so for high-risk groups who are difficult to access such as those with cognitive impairment in nursing homes. Of course, the most effective primary prevention strategies begin in adolescence with interventions aimed at improving peak bone mass in young adults. Epidemiological studies project that a 10% increase in peak bone mass would result in a 50% reduction in the risk of fracture in later life. 9 We know that of the modifiable factors that increase bone mass, physical activity and dietary intake have the most evidence 9 -justification, if ever it was needed, to tell our children to put down the game consoles and do more exercise.
The fracture liaison service model of secondary prevention has proven to be effective, but it is not delivered everywhere and there exists a global 'treatment gap'. 10 The UK has led the way in post hip fracture secondary prevention with the implementation of Fracture Liaison Services and the 'best practice tariff' as part of the largest ongoing audit of hip fracture care in the world -the National Hip Fracture Database (NHFD). 11 Hip fracture has become a 'marker' condition for fragility fracture care, but the NHFD standardised treatment pathways and key performance indicators are not necessarily applied to other severe fragility fractures such as fractures of the distal femur and fragility fractures around existing implants (periprosthetic fractures).
There is no justification for these injuries being treated differently from hip fractures. Improvements in all areas of fragility fracture care are vital if we are to continue to advance quality of care for patients, while coping with the projected increased workload.
The Global Fragility Fracture Network (FFN) is coordinating a Call to Action to meet these challenges. 12 This call has been endorsed by over 80 international organizations and has led to the development of national Fragility Fracture Networks in over 20 countries, representing half the world's population. The express mission of the national FFNs is to change policy in each of those countries, with the aim of improving the multidisciplinary acute management of patients with a fragility fracture, to improve rehabilitation services for these vulnerable patients and to implement effective secondary prevention strategies. For this to happen, leaders in nursing, anaesthetics, orthopaedics, rheumatology, geriatrics, osteoporosis/ metabolic bone disease and rehabilitation, all need to work together. Only by presenting a united front will policy makers and politicians heed this message.
In 2020, we will enter the WHO 'Decade of Healthy Ageing' which sets out 10 priorities to improve the global care of older people. 13 The priorities include themes of collecting better global data on healthy ageing, promoting research that addresses the needs of older people, developing global networks and making the economic case for investment in healthy ageing. These priorities are entwined with those of the FFN global Call to Action. This is the time. Our ability to meet the challenges of fragility fracture care in the future, will depend on the strategies we implement now.
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